Accueil>>δ9-THC-d9 (exempt preparation)

δ9-THC-d9 (exempt preparation)

Catalog No.GC48749

Products are for research use only. Not for human use. We do not sell to patients.

δ9-THC-d9 (exempt preparation) Chemical Structure

Taille Prix Stock Qté
100µg
87,00 $US
En stock
500µg
381,00 $US
En stock
1mg
674,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

δ9-Tetrahydrocannabinol-d99-THC-d9) contains nine deuterium atoms on the pentyl group. It is intended for use as an internal standard for the quantification of δ9-THC by GC- or LC-mass spectrometry. δ9-THC is a natural psychoactive compound found in plants of the genus Cannabis. This cannabinoid (CB) binds with high affinity to both the central CB1 receptor (Ki = 41 nM) and the peripheral CB2 receptor (Ki = 36 nM).1 δ9-THC, working primarily through these receptors, has diverse effects on perception, cognition, pain sensitivity, body temperature, the immune system, fetal development, and more.2 This product is intended for forensic and research purposes.

1.Huffman, J.W., Padgett, L.W., Isherwood, M.L., et al.1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptorsBioorg. Med. Chem. Lett.16(20)5432-5435(2006) 2.Grotenhermen, F.Pharmacokinetics and pharmacodynamics of cannabinoidsClin. Pharmacokinet.42(4)327-360(2003)

Avis

Review for δ9-THC-d9 (exempt preparation)

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for δ9-THC-d9 (exempt preparation)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.